Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic vancomycin before semi-permanent hemodialysis catheterization
IRCT20201206049617N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2020
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vancomycin in catheter infection (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Incidence of catheter-related infection and Time to catheter-related infection. Started Mar 2020; status: completed.
02
Drugs
vancomycin
03
Conditions
catheter infection
Beyond the preview
Go deeper on IRCT20201206049617N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201206049617N1.